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PREFACE 
Nanotechnology is considered as one of the key technologies of 21" century. It is 
expected to transform many industries in diverse ways and areas ranging from 
medicine to manufacturing. Research in nanoscale technologies is rapidly growing 
worldwide. It has been estimated that, by 2015, nanotechnology will have a $1 trillion 
impact on the global economy and will employ 2 million workers, 1 million of which 
may be in the United States (NIOSH, 2006). The increasing advances in 
nanotechnology have led to widespread applications of nanoparticles (NPs) in our day 
to day life. These minute particles are being used in cosmetics, electronics, catalysis. 
diagnostics and therapeutics. The increased production and utilization of the NPs are 
bound to enhance the problem of their harmful exposure in living system. Due to the 
extremely small size, NPs possess a greater surface area to volume ratio as compared 
to their bulk counterparts, which renders them highly reactive. As a result of this, they 
have the ability to interact with the biological systems resulting in various forms of 
toxicity. 
In view of the possible interactions of NPs with the biomolecules that may lead to 
harmful effects in the living system, there is an urgent need to develop rapid, accurate 
and efficient testing strategies to assess their potential hazards. Therefore, present 
work has been chosen to evaluate the toxicities of CuO and Ag NPs. The objective 
was to conduct a battery of toxicity tests targeting their phytotoxic, genotoxic and 
cytotoxic potentials. 
This dissertation begins with a brief introduction of the subject along with an 
overview on the available literature related to nanotechnology, nanoparticles" 
applications and nanotoxicology. The objectives of the study have also been included 
in this chapter. 
In the next chapter, various materials/chemicals used in the study are listed along with 
their sources, and the methods or protocols followed for different toxicity assays have 
been described. This chapter also contains the essential details of the characterization 
of the test nanoparticles. 
VII 
Third chapter entitled as 'Results' constitutes the elaboration of experimental 
findings. It also incorporates the graphical representations of all the data obtained 
after performing those toxicity tests. 
All the results obtained have been discussed under the heading of 'Discussion' as the 
last chapter. This component provides the scientific basis of the experimental data 
keeping a tab with the earlier findings and their explanations. 
The summary and the bibliography are presented at the end. 
VIII 
Cfiapter I: 
Introduction, Tleview of Literature 
ancCOBjectives 
Nanotechnology refers to the branch of science and engineering dedicated to 
materials, having dimensions in the range of 1-100 nm (Salata, 2004). This 
technology concerns with the manipulation of matter on a near-atomic scale to 
produce new structures, materials, and devices. It has a remarkable ability to 
transform many industries due to enormous potential of nanomaterials. Therefore, 
research in nanoscale technologies is rapidly growing worldwide. The National 
Science Foundation estimates that nanotechnology will have a $1 trillion impact on 
the global economy by 2015, and will employ around 2 million workers, 1 million of 
which may be in the United States (NIOSH, 2006). 
Nanotechnology has brought a new technological revolution that concerns almost 
every aspect of human life, making its presence felt in areas such as electronics, 
coatings, optical devices, energy, and medicine (Lux Report, 2008). In recent years, it 
has been embraced by industrial sectors due to its applications in the field of 
electronic storage systems (Kang et al., 1996), biotechnology (Pankhurst et al., 2003), 
magnetic separation and preconcentration of target analytes, targeted drug delivery 
(Rudge et al., 2001; Dobson, 2006) and vehicles for gene and drug delivery 
(Appenzeller, 1991; Kang et al., 1996; Rudge et al., 2001; Dobson, 2006). Although 
new, the history of nanomaterials dates long back to 1959, when Richard P. Feynman, 
a physicist at Caltech, USA, forecasted the advent of nanomaterials (Appenzeller, 
1991). As the field of nanotechnology advanced, novel nanomaterials became 
apparent having different properties as compared to their larger counterparts. 
According to the recent review published by the European Commission (2013), 
nanomaterial is defined as 'a natural, incidental or manufactured material containing 
particles, in an imbound state or as an aggregate or as an agglomerate, and where, for 
50 % or more of the particles in the number-size distribution, one or more external 
dimensions is in the size range of 1-100 nm. In specific cases and where warranted by 
concerns for the environment, health, safety or competitiveness, the number-size 
distribution threshold of 50 % may be replaced by a threshold between 1 and 50 %.' 
In scientific literatures, engineered (or manufactured or synthetic or man-made) 
nanoparticles (NPs) are usually defined as particles with at least one dimension 
between 1 and 100 nm. 
At nanoscale, materials have different or enhanced properties compared to their 
conventional 'bulk' (microsize) counterparts, due to an increased relative surface area 
that translates into higher reactivity (Nel et al., 2006). While in bulk materials the 
surface atoms constitute only a few percent of the total number of atoms, in NPs most 
of the atoms lay close to, or at the surface (Casals et al., 2012). There is increasing 
evidence that the unique physicochemical properties of NPs, which make them more 
efficient in industrial applications, also render these materials more harmful to living 
organisms. Due to increasing production of NPs and growing likelihood of 
occupational and environmental exposure to them, the legislative bodies in both EU 
and USA have currently focused their activities on assessing health and 
environmental risks of nanotechnology (Bondarenko et al., 2012) 
Depending on the origin, there are three types of NPs: natural, incidental and 
engineered. Natural NPs have existed from the beginning of the earth history and still 
occur in the environment (volcanic dust, lunar dust, mineral compositions, etc.). 
Incidental NPs, also defined as waste or anthropogenic particles, are. formed as a 
result of man-made industrial processes (diesel exhaust, coal combustion, welding 
fumes, etc.). Engineered NPs can be grouped into four types: (1) carbon based 
materials, usually including fullerenes, single walled carbon nanotubes (SWCNT) and 
multiwalled carbon nanotubes (MWCNT); (2) metal based materials, such as quantimi 
dots, nanogold, nanosilver, nanozinc, nanoaluminum and nanoscale metal oxides like 
TiOa, ZnO and A1203; (3) dendrimers which are nano-sized polymers built from 
branched units, capable of being tailored to perform specific chemical fimction; (4) 
composites which combine NPs with other NPs or with larger bulk-type materials 
(Lin and Xing, 2007) and form different morphologies such as spheres, tubes, rods 
and prisms (Yu-Nam and Lead, 2008). 
1. Applications of Nanoparticles 
Because of their peculiar characteristics, that are frequently different from the bulk 
materials, NPs find applications in many different fields. Some of their applications in 
cosmetics, biosensing, pharmaceutics, etc. are described below in detail: 
1.1. Nanoparticles in Medicine 
The field of nanomedicine is the science and technology of diagnosing, treating and 
preventing diseases and traumatic injuries using nanotechnology and molecular 
knowledge of the human body (WHO, 2004). In the last two decades, a number of 
nanoparticle-based therapeutic and diagnostic agents have been developed for the 
treatment of cancer, diabetes, pain, asthma, allergy, infections, and so on (Braimon-
Peppas and Blanchette, 2004; Kawasaki and Player, 2005). 
Two forms of nanomedicme that have already been tested in mice and are awaiting 
human trials, are those that will be using gold nanoshells to help diagnose and treat 
cancer (Sanjeev et al., 2013), and using liposomes as vaccine adjuvants and as 
vehicles for drug transport (Mozafari, 2006). Following are some of the medical 
applications of nanomaterials: 
1.1.1. Drug Delivery Systems: 
Nanoparticle drug delivery systems are nanometric carriers used to deliver drugs or 
biomolecules (Jung et al., 2000; Pinto et al., 2006). In conventional drug delivery, the 
drug concentration in the blood rises quickly, and then declines. Each drug has a 
plasma level above which it is toxic and below which it is ineffective. The main aim 
of an ideal drug delivery system is to maintain the drug within a desired therapeutic 
range after a single dose, and/or target the drug to a specific region while 
simultaneously lowering their systemic levels (Langer, 2003). 
Examples of nanoparticles applications in drug delivery include: 
1. Abraxane, approved by the U.S. Food and Drug Administration (FDA) to 
treat breast cancer, non-small-cell lung cancer (NSCLC) and pancreatic 
cancer, is the nanoparticle of albumin bound paclitaxel. 
2. Doxil® was originally approved by the FDA for the use on HIV-
related Kaposi's sarcoma. It is now also being used to treat ovarian cancer and 
multiple myeloma. The drug is incased in liposomes, which helps to extend its 
life while being distributed (Martis et al., 2012). 
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3. Researchers at Case Western Reserve University, USA, reported the delivery 
of doxorubicin to breast cancer cells by means of NP chain in a mice study 
(Pubuduetal.,2012). 
4. Using the biomimetic strategy, researchers in the Harvard University, 
USA, demonstrated in a mouse model that the drug coated NPs can dissolve 
blood clots by selectively binding to the narrowed regions in the blood vessels, 
just like the platelets do (Wyss Institute, 2012). 
5. Researchers at The Methodist Hospital Research Institute, Houston, have 
created 'LeukoLike Vectors' or LLVs. These are the drug-carrying silicon NPs 
coated with the lipoprotein removed from the membranes of the white blood 
cells, leukocytes. The 'cloaked' NPs were found to behave like leukocytes, are 
able to evade the body's immune system and survive much longer in 
vivo when studied in mice (Ennio et al., 2012). 
6. Self-powered NPs with a payload of osteoporosis drug are reported to be 
pulled towards the fresh bone crack site, powered by the ion 
gradients generated by the leaked minerals (ions) from the bone, and deliver 
highly targeted drugs for healing (Vinita et al., 2013). 
7. Nanodiamonds are the diamond particles with a diameter of 2-8 nm, having 
surface functional groups to bind various kinds of molecules. Clusters of the 
nanodiamonds in the range of 50-100 nm in diameter can be manufactured to 
trap drug inside and slowly release the payload (Dean, 2013). 
8. In regenerative medicine research, silica based NPs are used to deliver 
molecules to transplanted cells derived from stem cells (Alfonso et al., 2013). 
1.1.2. Surgery: 
At Rice University, USA, a flesh welder is used to fiise two pieces of chicken meat 
into a single piece. The two pieces of chicken are placed together, touching each 
other. A greenish liquid, containing gold-coated nanoshells is dribbled along the 
seam. An infra-red laser is traced along the seam, causing the two sides to weld 
together. This could solve the difficuUies and blood leaks caused when the surgeon 
tries to restitch the arteries that have been cut during a kidney or heart transplant. The 
flesh welder could weld the artery perfectly (Gobin et al., 2005). 
4-
1.1.3. Visualisation/ Imaging: 
In a study published online in Nature Medicine, a team led by Prof. Gambhir showed 
that, the minuscule NPs engineered in his lab homed in and highlighted brain tumors, 
precisely delineating their boundaries and greatly easing their complete removal. The 
new technique could someday help improve the prognosis of patients with deadly 
brain cancers. The NPs used in the study are essentially tiny gold balls coated with 
imaging reagents (Gambhir et al., 2012). 
1.1.4. Cancer Therapy: 
Nanoparticles can deliver anti-cancer agents to tumor sites by two strategies namely: 
active and passive, that offer significant benefits to cancer patients (Liu et al., 2007; 
Byme et al., 2008). Passive targeting enables nanodrugs to accumulate in tumor 
tissues. The highly disorganized and dilated tumor vessels resulting in enlarged gap 
jtinctions between endothelial cells allows extravasation of NPs into extra-vascular 
space (Jain, 2001; Duncan, 2003; Brannon-Peppas and Blanchette, 2004). Active 
targeting of tumor cells is done by conjugating targeting moieties to NPs leading to 
their accumulation in tumor sites (Ulbrich et al., 2004; Xu et al., 2005; Cheng et al., 
2007; Diez et al., 2009). 
A recent study published by Dhar et al. (2013), reports a new cancer treatment 
technique that uses NPs to reprogram immune cells so that they are able to recognize 
and attack cancer cells. Treatments based on heat generation at the tumor site 
(hyperthermia), is an attractive method of tumor therapy. Magnetic NPs have been 
reported to generate heat by various mechanisms under alternating magnetic field 
(Tartaj et al., 2003). 
1.1.5. Antimicrobial Effects: 
Metal based NPs ftmction as effective antimicrobial agents against common 
pathogenic microorganisms. Therefore, some of the NPs such as silver, titanium 
dioxide and zinc oxide are receiving considerable attention as antimicrobials and 
additives in consumer, health-related and industrial products (Dibrov et al.. 2002). 
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Silver NPs are increasingly being incorporated into various matrices to extend their 
utility in materials and biomedical applications (Sarkar et al., 2007). They are used as 
additives in health related products such as bandages, catheters, and other materials to 
prevent infection, particularly during the healing of wounds and bums (Baker et al., 
2005). Zinc oxide (ZnO) and copper oxide (CuO) nanomaterials, due to their 
antimicrobial property, are being incorporated into a variety of medical and skin 
coatings. ZnO NPs are used in the wallpapers in hospitals, and as an active ingredient 
for dermatological applications in creams, lotions and ointments (Martinez et al., 
2003). 
1.2. Nanoparticles in Cosmetics 
Nanoparticles of titanium dioxide (TiOa) and zinc oxide (ZnO) are used as UV light 
filters in sunscreens, because of their ability to efficiently reflect and scatter UV 
radiations (Patel et al., 2011). This provides protection to the consumers fi-om the 
harmful effects of UV exposure (WHO, 1998; Nohynek and Schaefer, 2001; Gelis et 
al., 2003). Silver NPs possessing anti-bacterial properties have been increasingly used 
in variety of consumer products like soaps, shampoo, conditioners, toothpastes, 
deodorants, antiwrinkle cream, moisturizer, foundation, face powder, lipstick, etc. 
(Salata, 2004). In order to increase the stability of the incorporated agents as well as 
the system itself, solid lipid NPs (SLN) and nanostructured lipid carriers (NLC) have 
been developed (Miiller et al., 1998). 
1.3. Nanoparticles in Biosensing 
For biomedical diagnosis, forensic analysis, and environmental monitoring, the 
sensing of biological agents and toxic materials is important (Rosi and Mirkin, 2005). 
A sensor usually has two components: a recognition element, that binds the target 
molecule and a transduction element, that signals the binding event. The inherent 
increase in signal-to-noise ratio resuhing from the miniature size of the NPs (Sheehan 
and Whitman, 2005), together with their unique physicochemical properties (Rosi and 
Mirkin, 2005), enable such systems to become good biosensors (Daniel and Astruc, 
2004). For instance, based on their shape and size, gold NPs exhibit unique optical 
and electronic properties showing an intense absorption peak from 500-550 nm (Jain 
et al., 2006) arising from surface plasmon resonance (Mie, 1908). 
2. Nanotoxicology 
Nanotoxicology was proposed as a new branch of toxicology to address the gaps in 
knowledge, and to specifically address the adverse health effects likely to be caused 
by nanomaterials (Donaldson et al., 2004). In the original article on nanotoxicology. 
Donaldson et al. (2004) quoted, "discipline of nanotoxicology would make an 
important contribution to the development of a sustainable and safe nanotechnology". 
Nanotoxicology encompasses the physicochemical determinants, routes of exposure, 
biodistribution, molecular determinants, genotoxicity, and regulatory aspects. In 
addition, nanotoxicology is involved in proposing reliable, robust, and data-assured 
test protocols for nanomaterials in human and environmental risk assessment 
(Donaldson et al., 2004; Lewinski et al., 2008). 
The widespread applications of NPs lead to a remarkable increase in their production 
and utilization in the recent years. Therefore, the enviromnental and occupational 
exposure to NPs is likely increasing and may represent a source of health risk, which 
calls for an urgent need to develop rapid, accurate and efficient testing strategies to 
assess their biological effects (Hu et al., 2009). Among the different exposure routes, 
inhalation seems to be the more critical; there are significant differences between NPs 
and larger particles regarding their distribution pattern into the respiratory system. 
Moreover, the common mechanism of clearance often becomes ineffective 
(Oberdoster et al., 2005). Thus, the inhaled nanosized materials are either lodged 
within the respiratory apparatus or translocated to other target organs. Furthermore, 
with a reduction in size, the properties can change dramatically regarding electrical 
conductivity, magnetic characteristics, hardness, active surface area, and chemical as 
well as biological activity (Karlsson et al., 2008). Chemical analysis of ultrafine 
particles (UFPs) has revealed relatively higher presence of metal oxide NPs at sites 
surrounding factories, when compared to clean areas (Rogaczewska and Matczak. 
1985), and epidemiological studies have reported a conelation between the level of 
UFP and the increase in pulmonary diseases including exacerbation of bronchial 
asthma (Weichenthal et al., 2007). It has been suggested that different metal oxide 
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NPs are able to generate oxidative stress and affect ceil viability through the redox 
potential associated to transition metals (Fahmy and Cormier, 2009), but the role of 
particles' nanostructure in eliciting toxic response remains to be fully understood. 
Toxicities of nanoparticles have been reported in mammalian cell lines (Hussain et al., 
2005; Brunner et al., 2006), plants (Lin and Xing 2007, 2008), crustaceans (Lovem et 
al , 2007; Roberts et al , 2007; Baun et al., 2008), fish (Oberdorster, 2004; Griffitt et 
al., 2007; Smith et al., 2007) and mice (Wang et al., 2007). They also present potential 
risks to human health because they have been shown to be toxic to human lung cells 
(Worle-Knirsch et al., 2007) and red blood cells (Rothen-Rutishauser et al., 2006). 
Human exposure is also quite obvious because so many customer products have 
utilized NPs. Moreover, after NPs find their way into the environment, they may end 
up in the ecosystem food web through direct uptake of water or food, potentially 
leading to human exposure through food, drinking water, and/or recreational 
activities. NP release into the environment is inevitable because of their increasing 
production and application. Many new types of nanomaterials have been released in 
great amounts (Nowack and Bucheli, 2007), while their potential toxicity and harm to 
the organisms and ecosystems remain unknown. Both scientists and the public need a 
better understanding of behavior and effects of this new material group in the 
ecosystem. It is important to consider environmental, health and safety aspects at an 
early stage of nanomaterial development and use, in order to identify and manage 
potential human and envirormiental health impacts more effectively fi-om their 
exposure (Baun et al., 2008). 
Nanoparticles may enter the human body via different routes, for instance, respiratory 
route, dermal route, gastro-intestinal route, etc. Once in the bloodstream, they can be 
transported around the body and be taken up by various organs and systems like liver, 
spleen, lungs, and nervous system, and lead to tissue or organ injury (Warheit et al., 
2004; Oberdorster et al., 2005; Li et al., 2007). 
2.1. Sources of Nanoparticles Exposure 
Every organism on earth has been exposed to a variety of nanometer-sized particles. 
A vast majority of them generally goes unnoticed without causing any ill effect, but 
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occasionally any one may cause appreciable harm to the organism. There are various 
sources of NPs to which humans are exposed; some of the sources given here under 
include factories, industries, cosmetics, biosensors, food, electronics, various medical 
therapies, etc. 
2.1.1. Natural Sources: 
Nanoparticles are quite abimdant in nature, as they are produced and released in many 
natural processes, like volcaiuc eruptions, photochemical reactions, forest fires, 
oceans and water evaporation, dust storms and simple erosion. They are also released 
by plants and animals especially when they shed their skin and hair. Though air 
pollution is usually associated with human activities like industries, automobiles and 
charcoal burning, natural events can lead to the generation of such huge amounts of 
NPs that they immensely affect air quality worldwide. The estimated production of 
aerosols as a result of human activities is only about 10% of the total, the remaining 
90% being generated naturally (Taylor, 2002). 
Major forest fires and grass fires, primarily caused by lightning strikes or human 
activities, can spread ash and smoke over thousands of square miles, leading to an 
immense increase in particulate matter, including NPs (Sapkota et al., 2005). During a 
volcanic eruption, ashes and gases containing enormous quantity of particles scaling 
fi-om nano to micron size are expelled high into the atmosphere (Taylor, 2002). One 
particularly harmful volcanic product is particles composed of heavy metals, as these 
are well known toxicants for humans. While some effects are seen worldwide, the 
highest levels of particulate matter are found in areas within tens of kilometers from 
the volcano (Yano et al., 1990). 
2.1.2. Anthropogenic Sources: 
Humans are producing vast quantity of nanoparticulate matter as by-products of 
simple combustion, food cooking, automobile exhaust, chemical manufacturing, 
smelting, ore refining, welding, etc. Diesel and automobile exhaust, in urban areas, is 
the primary source of atmospheric nano- and microparticles (USEPA, 2002). Most of 
these are in the size range of 20-130 nm for diesel engines and 20-60 nm for gasoline 
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engines (Sioutas et al., 2005; Westerdahl et al., 2005) and are typically roughly 
spherical in shape. Cigarette is a very common source of nanosized particles. As a 
combustion product, tobacco smoke is composed of around 10-700 nm sized NPs 
with a maximum size around 150 nm (Ning et al , 2006). Demolition of large 
buildings can give rise to high levels of particulate matter, especially the respirable 
ones, smaller than 10 microns in diameter. Older buildings are very likely to contain 
known toxic materials and therefore, their site of demolition may found to have 
respirable asbestos fibers, lead, glass, wood, paper, and other toxic particles. In 
addition, the dust cloud can travel tens of kilometers and affect the neighboring 
regions as well (Stefani et al., 2005). 
Many cosmetics (cream, foundation, lipstick, face powder, nail polish, eye shadow, 
blush and after-shave lotion), simscreens and personal care products (deodorant, soap, 
hair conditioner, shampoo, toothpaste) incorporate NPs. Titanium dioxide (TiOi) 
particles of size larger than 100 nm diameter are considered biologically inert in both 
humans and animals (Gurr et al., 2005), and are therefore, widely used in many 
products, such as white pigment, food colorant, sunscreens and cosmetic creams 
(Donaldson et al., 2004). Silver NPs are being used as antibacterial/antiftingal agents 
in a diverse range of products like air sanitizer sprays, socks, pillows, slippers, face 
masks, wet wipes, detergents, soaps, shampoos, toothpastes, air filters, coatings of 
refrigerators, vacuum cleaners, washing machines, food storage containers, cellular 
phones, etc. (Stensberg et al., 2011). 
2.2. Routes of Entry into the Human Body for Nanomaterials 
Due to the advances in nanotechnology, and the potential risks associated with the 
exposure to NPs, h is necessary to clearly understand the possible routes of their entry 
into the body. In fact, these may enter the human body either naturally 
(unintentionally) or intt-oduced artificially (intentionally) through the skin, lungs or 
intestinal tract, resulting in deposition in several organs and therefore, may cause 
adverse biological effects (Kol and Santini, 2004; Hansen and Autumn, 2005; Sioutas 
et al., 2005; Kahn, 2006). It has been demonsttated that NPs gain access to the body 
mainly via the airways, the skin or via ingestion (Stem and McNeil, 2008). Other 
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potential routes of exposure include parental administration such as intravenous, 
intradermal and peritoneal injections. 
2.2.1. Respiratory Route: 
The most common route of exposure to NPs is by inhalation. These can be inhaled 
naturally in the form of aerosol, powders or artificially by instillation into the 
respiratory tract for toxicity studies (Peter et al., 2004; Warheit et al., 2004-. 
Oberdorster et al., 2005). For example, studies done by Warheit et al. (2004) and Li et 
al. (2007) suggest that NPs can be instilled via intratracheal, oropharyngeal and 
intrapharyngeal, when determining their toxicity in respiratory tract of animals. Once 
inhaled, these can be transported from the upper to the lower respiratory tract in the 
bronchioles by the electrostatic force of air (Oberdorster et al., 2005; Cross et al., 
2007). 
The human respiratory tract consists of three sequential regions, assisting the filtration 
effect, including nasopharyngeal, tracheobronchial and the pulmonary regions. 
However, considering the vast internal surface area of the alveoli and airways that 
facilitates broad access of inhaled materials to the limg tissue, this system cannot 
always deal adequately with the wide range of airborne materials that may occur in 
urban or occupational environments (Blank et al., 2009). 
After inhalation, NPs tend to deposit in the complete respiratory tract, starting from 
nose and phrynx down to the lungs (Oberdorster, 2001; Elder et al.. 2006). The 
deposition of NPs in the respiratory tract is usually determined by the particle's 
diameter. The nasopharyngeal region mainly captures the microparticles and the NPs 
smaller than 10 nm, while the lungs will receive mainly those of 10-20 nm range 
(Oberdorster, 2001). The discrete NPs that are deposited in the nasal region have been 
found to enter the brain by translocation via the olfactory nerve of experimental 
animals (Flesken et al., 2007). Also when the NPs are deposited in the alveolar region, 
they are usually attacked by the phagocytes leading to chemotactic activities which 
trigger the complement system cascade and the inflammatory cell response. 
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2.2.2. Gastro-intestinal Route: 
The gastrointestinal tract (GIT) exposures usually occur either unintentionally from 
hand to mouth transfer or from traditional materials or during handling of the 
materials that contain NPs. Endogenous sources of NPs are derived from intestinal 
calcium and phosphate secretion (Lomer et al., 2004) whereas exogenous sources are 
those from food, pharmaceuticals, water, cosmetics (Lomer et al., 2004), dental 
prosthesis debris (Ballestri et al., 2001) and inhaled particles (Takenaka et al., 2001). 
The use of specific products, such as salad dressings containing Ti02 nanoparticle as a 
whitening agent, can lead to an increase by more than 40 fold of the daily average 
intake (Oberdorster, 2004). These NPs do not degrade with the passage of time and 
accumulate in macrophages. Other possible GIT exposures may come from particles 
cleared from the respiratory system through the mucociliary escalator (Obordorster et 
al., 2005; Chen et al., 2006; Li et al., 2007). 
The gastro-intestinal tract is a complex barrier-exchange system, and is the most 
important route for macromolecules to enter the body. The absorption of particles in 
GIT depends on their size, and it decreases with increase in particle size (Jani et al., 
1990). NPs administered orally are usually absorbed through the epithelial cells of the 
Peyer's patches in the gut-associated lymphoid tissue (GALT) and also through the 
gut enterocytes (Alexander, 2005; Chen et al., 2006). Ingestion of UFPs by GIT can 
stimulate phagocytosis at the GI mucosa and cause antigen-antibody mediated 
reactions and inflammatory responses that spread systematically from there to other 
organs of the body (Hussain et al., 2001). 
2.23. Dermal Route: 
The interaction of NPs with skin is of great concern because of their increasing use in 
cosmetics, sunscreens and stain-resistant clothing. The dermal route of exposure is 
also important because of the tendency of agglomerated airborne NPs to settle on skin 
surface and the impossibility to prevent their contact with the skin. Studies have been 
done, examining the ability of nanoTi02 (a UV-absorbing component of sunscreens) 
to penetrate the epidermis of human volunteers, rats and in vitro models (Shinde et al., 
2012). 
-12-
Nanoparticles typically penetrate the skin through hair follicles (Toll et al., 2004) and 
flexed (Tinkle et al., 2003) and broken skin (Oberdorster et al., 2005). This is 
mediated by passive diffusion and they are found to be localized within the dermal 
layers of the stratum corenum within 8 to 24 hours. Internalization of MWCNTs by 
human epidermal keratinocytes in cytoplasmic vacuoles induces the release of pro-
inflammatory mediators (Monteiro-Riviere et al., 2005) leading to oxidative stress and 
decreased viability (Monteiro- Riviere et al., 2008). 
Findings by Tinkle et al. (2003) have shown that NPs less than 1 [xm in diameter may 
penetrate the skin mechanically. Other NPs such as Ti02 and ZnO have also been 
reported as key particles that are capable of penetrating, when applied topically to 
human skin in vitro (Friedlander and Pui, 2003). Spherical particles of size range 
between 750 nm and 6 microns selectively penetrate the skin at hair follicles with a 
maximum penetration depth of more than 2.4 mm (Toll et al., 2005). Broken skin 
provides way for the entry of a vvade range of larger particles (500 nm - 7 |im) 
(Oberdorster et al., 2005). Thus, skin barrier alterations like wound, scrapes or 
dermatitis could act as exposure routes to NPs into the body and should not be 
overlooked. 
2.3. Different Forms of Nanoparticle-Induced Toxicity 
2.3.1. Organ Toxicity: 
Recent research has suggested that, even low concentration of NPs can have harmful 
effects on health, and none of them are completely inert (Ferrin, 2004). Inhalation of 
NPs may cause damage to the lungs resulting from impaired macrophage clearance, 
inflammation, accumulation of particles, and epithelial cell proliferation, followed by 
fibrosis, emphysema, and appearance of tumors (Ferrin, 2004; Borm et al., 2004; 
Oberdorster et al., 1994; Dasenbrock et al., 1996; Driscoll et al., 1996; Nikula et al., 
1995). Respiratory uptake of these may also affect the ability of the immune system to 
fight with the infections and may lead to thrombosis (Vermylen et al., 2005), as well 
as, cardiovascular diseases. Once entered the circulatory system, NPs may reach 
different organs where they may cause toxic effects leading to various diseases; for 
instance, upon intestinal absorption of dental prosthesis debris, severe health 
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conditions can occur, that include fever, enlarged liver and spleen, reduced bile flow 
and acute renal failure (Ballestri et al., 2001). Moreover, diseases caused by gastro-
intestinal uptake of NPs include Crohn's disease and ulcerative colitis. 
2.3.2. Cytotoxicity: 
To study the reaction of a foreign agent inside the body, cell-culture study is an initial 
step. In comparison to in vivo studies, cytotoxicity assays are cheaper and easier to 
control and reproduce. NP-induced cytotoxicity has been reported by several groups 
(Drezek et al., 2008). According to Chang et al. (2012), there are three different 
mechanisms of copper NP-induced toxicity to eukaryotic cells. These are based on 
oxidative stress, coordination effects and non-homeostasis effects. They suggested 
that NPs may enter the cells either by diffusion through the pores in the cell 
membrane, via ion channels and transporter proteins on the plasma membrane, or by 
the process of endocytosis. After entry into the cell, they can interact directly with the 
oxidative organelles such as mitochondria and the redox active proteins, as well as the 
ions (Cu^^) produced by the NPs, and then lead to the production of reactive oxygen 
species (ROS) which further cause DNA damage. Ions released by the NPs increase 
their local concentration and disrupt the cellular metal cation homeostasis. Similarly, 
Ag NPs were also shown to possess toxic effects in various cytotoxicity assays. They 
were found to exhibit significant cytotoxic effects against in vitro HeLa cancer cell 
lines with IC50 value of 200 ^g/ml (Manivasagan et al., 2013). 
2.3.3. Genototoxicity: 
Genotoxicity may either be a resuU of direct interaction of NPs with the genetic 
material or indirect damage fi-om NP-induced ROS, or toxic effects of ions released 
by the NPs (Kisin et al. 2007; Barnes et al., 2008). In vitro studies done by Barillet et 
al. (2010) have shown that smaller NPs may enter the nucleus via nuclear pores (8-10 
nm diameter), whereas larger particles (15-60 nm) may interact with DNA only in 
dividing cells when the nuclear membrane dissolves (Liang et al., 2008; Singh et al., 
2009). Large aggregates of NPs may deform the nucleus (Di Virgilio et al., 2010) that 
could in turn affect mitosis, resulting in incorrect chromosomal segregation and 
impaired functioning of mitotic spindle and its components. Moreover, they may 
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directly interact with the chromosomes and damage them (Magdolenova et al., 2013). 
Ag NPs have been shown to exhibit concentration-dependent cytotoxicity and 
genotoxicity in human lymphocytes (Li et al., 2012). For instance, 100 and 200 ^g/ml 
concentration of starch-coated Ag NPs were found to damage DNA along with 2-3 
fold increase in micronucleus frequencies in IMR-90 human lung fibroblasts and 
U251 human glioblastoma cells (Asharani et al., 2009). 
2.3.4. Phytotoxicity: 
To establish a toxicity profile for NPs, phytotoxicity in higher plants should be 
evaluated (USEPA, 2005). For this purpose, seed germination and root elongation 
assay is a rapid, sensitive, simple and cheap phytotoxicity test (Munzuroglu and 
Geckil, 2002; Wang et al., 2001). Seed germination is a normal physiological process 
that is initiated with imbibition of water by seeds and terminated after rootlets are 
emerged (Kordan, 1992). 
Different NPs affect root growth differently, among different plant species. The NP-
induced phytotoxicity is altered by the surface modification of these particles (Ma et 
al., 2010). Studies have demonstrated that it is also possible for some NPs to have 
either positive or no significant effects on plants. For instance, up to 4000 mg/l 
concentration, AI2O3 NPs had no significant toxic effects on seed germination, root 
elongation, and number of leaves of Arabidopsis thaliana (Lee et al., 2010). CuO NPs 
are shown to damage DNA in some agricultural plants like Raphanus sativus, LoUum 
perenne, and Lolium rigidum (Atha et al., 2012). 
2.4. Proposed Mechanisms of Nanoparticle Induced Toxicity 
Though the exact mechanism of nanoparticle toxicity is not known, the generation of 
reactive oxygen species (ROS) and thereby, oxidative injury is considered to be the 
major toxicological mechanism (Margriet, 2012). It has been proposed that these 
nanosized particles generate ROS either fi-om an innate immune response to them or 
due to the autocatalytic generation by some specific particles (Babior, 1987; Xia et al.. 
2006). Various NPs (e.g. ftiUerenes, carbon nanotubes, automobile exhaust and 
quantum dots) have been shown to generate ROS both in vitro and in vivo 
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(Oberdorster et al, 2005). These ROS present in cellular environment have the 
potential to peroxidize lipids, interfere with signaling processes, modulate gene 
transcription or damage DNA; thereby, leading to cell damage or finally cell death 
(Brown et al., 2004). 
Due to the large surface area possessed by them, NPs exhibit higher surface reactivity 
and, therefore, generate more free radicals and ROS than larger particles (Stone et al., 
1998; Wilson et al., 2002; Sioutas et al , 2005; Nel et al., 2006). ROS generation may 
occur either directly from the NPs' surface or from the catalysis of Fenton-type 
reactions by the NPs of transition metals namely copper, chromium, iron, etc. e.g: 
•O2 + H2O2 • OH + 'OH + O2 
reduction of hydrogen peroxide (H2O2) in presence of ferrous ion (Fe^ "^ ) as catalyst 
results in the formation of highly reactive hydroxyl radicals ('OH) (Risom et al., 
2005). NPs may be phagocytosed by the inflammatory cells like alveolar 
macrophages and neufrophils leading to their activation that result in generation of 
ROS and RNS (reactive nifrogen species) (Long et al., 2004; Risom et al., 2005). 
Moreover, NPs may enter mitochondria (Li et al., 2003; Xia et al., 2006) altering ROS 
production and interfering with antioxidant defence system (Oberdorster et al., 2005). 
Low levels of ROS are normally generated during cellular processes such as 
mitochondrial respiration, and these are immediately neutralized by the cell's 
antioxidant machinery. But when the level exceeds the cell's antioxidant capacity that 
leads to the induction of oxidative sfress (Margriet, 2012). 
Nanoparticles may induce inflammatory and allergic responses in the lungs by 
interacting with their immune cells (Inoue and Takano, 2011). Inflammation is a 
body's normal response to tissue injury. Moderate induction stimulates the 
regeneration of healthy tissues; but excess of it may cause a disease (Donaldson and 
Stone, 2003). The induction of oxidative stress may lead to a release of cytokines or 
pro-inflammatory mediators that alters the immune system (Brown et al., 2004; Long 
et al., 2004). However, there are some NPs that can cause cell death by damaging 
mitochondria, without inducing inflammation (Xia et al., 2006). Thus, sustained 
inflammation and oxidative stress in lungs and brain tissues resulting from NP 
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exposure is probably the root cause of lung fibrosis and neurodegenerative diseases 
respectively (Brook et al., 2010; Simko and Mattsson, 2010). 
Induction of oxidative stress may cause oxidation and therefore, damage to cellular 
biomolecules like DNA, leading to genetic mutations (Risom et al., 2005; Peters et al . 
2006). For example, histone modifications may result in opening of supercoiled DNA 
that leads to structural alteration (Donaldson and Stone, 2003). Various nanomaterials 
(transition metals, welding fiimes, carbon black) have been shown to be genotoxic to 
humans and rats in both in vitro and in vivo studies (Donaldson et al., 2005). 
The basic molecular events involved in NP-induced toxicity would be the generation 
of ROS either directly or by activation of macrophages (Long et al., 2004: 
Oberdorster et al., 2005; Risom et al., 2005), leading to the induction of inflammation 
(Brown et al., 2004; Long et al., 2004). Macrophage activation alters the intracellular 
calcium concentration inducing further ROS production and amplifying calcium 
signaling leading to calcium depletion (Lim et al., 1997; Brown et al., 2004; Risom et 
al., 2005). NPs may directly interact with epithelial cells (Risom et al., 2005) resulting 
in increased inflammation. Finally, NPs' interaction with cells may also cause DNA 
modifications, cell injury and diseases (Donaldson and Stone, 2003). 
3. Nanoparticles Selected for this Study: An Overview 
3.1. Copper Oxide Nanoparticles (CuO NPs) 
3.1.1. Applications: 
CuO NPs possess several novel characteristics such as improved fluid viscosity and 
enhanced thermal conductivity that make them potentially useful energy-saving 
material (Namburu et al., 2007). They are being used in different areas including gas 
sensors (Chowdhuri et al., 2004), catalysis (Jammi et al., 2009), batteries (Zhang et 
al., 2005), high temperature superconductors (Dar et al., 2008), solar energy 
conversion (Yin et al., 2005), optical and recording devices (Vassiliou et al., 1993: 
Prinz, 1999), purification of enzymes and other biological materials (Airapetyan et al.. 
2001), and targeted drug delivery (Wellman et al., 1998). Because they can reduce 
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friction (Hernandez et al., 2008) and mend worn surfaces, they are used as additives 
in lubricants, polymers/plastics, and metallic coatings (Hernandez et al., 2010). 
Moreover, the extremely high surface areas and unusual crystal morphologies endow 
these particles with antimicrobial activity, and they dose-dependently inhibit 
Escherichia coli strains, but not Salmonella typhimurium (Pan et al., 2010). 
3.1.2. Toxicological aspects: 
Studies have shown that CuO NPs induced severe acute inflammatory changes in rats' 
lungs at high doses and chronically at low doses or with frequent instillations. 
Karlsson et al. (2008) reported that these nanomaterials could cause cytotoxicity and 
DNA damage in the human lung epithelial cell line A549. Oxidative lesions were 
verified by measuring intracellular production of ROS with the oxidation-sensitive 
fluorescent probe, 2',7'-dichlorofluorescin diacetate (DCFH-DA). After comparing 
the relationship between ROS generation and DNA damage, oxidative stress was 
proved to be the primary toxic effect (Wang et al., 2012). Cells exposed to CuO NPs 
exhibited reduced catalase and glutathione reductase (GR) activities and increased 
glutathione peroxidase (GPx) activity. The observed increase in the ratio of oxidized 
to reduced glutathione suggested that these particles not only generated ROS, but also 
blocked cellular antioxidant defenses (Fahmy and Cormier, 2009). 
The key factors responsible for CuO NP toxicity include, nanosize, nanosurface, 
dissolution, self-assembly, quantum effects, concentration, and aggregation (Yan et 
al., 2011). Cationic NPs may enter cells more easily than anionic NPs, because of 
their interaction with heparin sulfate proteoglycans present on the membrane surface 
(Tyagi et al., 2001; Wadia and Dowdy, 2005). 
ROS generation and oxidative stress induction are the major toxicological 
mechanisms of ambient NPs (Toduka et al., 2012). Many studies have shown that NP 
exposure elevates cellular oxidative stress (Lin et al., 2006a,b; Limbach et al., 2007; 
Lin et al., 2008; 2009; Fahmy and Cormier, 2009). These particles can interact 
directly with oxidative organelles such as mitochondria, where the redox active 
proteins stimulate the generation of ROS in cells. Moreover, the ions produced by the 
NPs can also induce ROS by various chemical reactions which can ftirther lead to the 
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induction of DNA strand breaks, affecting gene expression. Excessive oxidative stress 
may modify proteins, lipids, and nucleic acids, leading to cell death (Yang et al.. 
2009). Moreover, Cu^^ ions have the ability to form chelates with biomolecules or 
dislodge the metal ions in specific metalloproteins, resulting in functional protein 
inactivation. CuO NPs may release Cu^ "^  which increases the local concentration of 
metal ions, and once the level exceeds the physiological tolerance range, toxicity 
occurs (Zietz et al., 2003; Galhardi et al., 2004). The potential role of dissolved ions 
in toxicity was also highlighted in a study by George et al. (2010). Exposure to NPs 
has also been found to result in oxidative stress-induced activation of pro-
inflammatory factors such as IL-1, IL-6, IL-8, and macrophage inflammatory proteins 
(MI?) at both mRNA and protein levels in vitro (Monteiller et al., 2007; Singh et al.. 
2007; Braydich-Stolle et al., 2010; Goncalves et al., 2010; Kahn et al., 2010; 
Karthikeyan et al., 2010; Liu and Sun, 2010; Wu et al., 2010). 
3.2. Silver Nanoparticles (Ag NPs) 
3.2.1. Applications: 
Silver nanoparticles have become one of the leading nanomaterials used in various 
consumer products. While they have potential applications due to their unique optical 
properties, the primary application exploits their potent anti-microbial properties 
(Chen and Schluesener, 2008; Hwang et al., 2008; Liu et al., 2010; Sotiriou et al.. 
2011; Rai et al., 2012). They are used extensively as anti-bacterial agents in the health 
industry, food storage, and textile coatings and are being incorporated into consumer 
products like, contraceptives, cosmetics, children's toys, medical equipment, air 
filters, water filters, and residential washing machines (Stensberg et al., 2011). 
Moreover, due to the electrochemical properties, they are used in nanoscale sensors 
providing faster response times and lower detection limits (Abou El-Nour et al., 
2010). However, most important application of Ag NP is in the treatment of diseases 
requiring maintenance of circulating drug concentration or targeting of specific cells 
or organs (Panyam and Labhasetwar, 2003; Moghimi et al., 2001). 
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3.2.2. Toxicological aspects: 
Because of the growing applications of nanosilver in common consumer products, 
concerns are being raised over tlie potential harmful effects of these nanomaterials to 
humans and environment (Benn et al., 2010). 
The toxicity of Ag NPs has been largely investigated using both in vitro and in vivo 
systems and these NPs were found toxic to a variety of tissues including lung, liver, 
brain, vascular system and reproductive organs (Ahamed et al., 2010). The in vitro 
studies showed that exposure to these particles can cause genotoxicity because of 
increased oxidative stress (Asharani et al., 2009; Park et al., 201 la; Piao et al., 2011). 
Similarly, other findings confirm Ag NP induced cytotoxicity and reactive, oxygen 
species (ROS) generafion (Carlson et al., 2008; Asharani et al., 2009; Park et al., 
2011a, b; Piao et al., 2011). Carlson et al. (2008) demonstrated a significant 
dose-dependent and size-dependent decrease in mitochondrial fiinction (MTT assay), 
mitochondrial membrane integrity (LDH assay), ROS generation (DCFH-DA assay), 
release of inflammatory cytokines (TNF-a, MIP-2, and IL-ip) and glutathione 
depletion in rat alveolar macrophages. Lungs and liver were found to be the major 
target tissues for prolonged Ag NP exposure (Takenaka et al., 2001; Sung et al., 
2008). Studies on rat liver cells have reported significant depletion of the antioxidant 
glutathione, reduction in mitochondrial membrane potential and increase in ROS 
(Hussain et al., 2005). These findings suggested that Ag NP cytotoxicity is likely 
mediated through oxidative stress in liver cells. 
Particle size of nanomaterials is considered as an important physical characteristic, 
often predictive of toxicity (Oberdorster et al., 2005; Nel, 2006; Nel et al., 2012). 
Studies have shown that Ag NPs undergo oxidative dissolution in systems where 
oxygen and protons are present, resulting in the release of silver ions (Ag ) in solution 
over fime (Lok et al., 2007; Kittler et al., 2010; Liu and Hurt, 2010; Zhang et al., 
2011; Ma et al., 2012). This leads to the production of hydrogen peroxide and 
depletion of both dissolved oxygen and protons (Liu and Hurt, 2010), which could 
contribute to ROS generation. The toxicity of many NPs has been found to be 
associated with the release of metal ions, with higher rates of dissolution resulting in 
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increased toxicity (Lok et al., 2007; Kittler et al., 2010). Although, Ag ions 
contribute significantly to the toxicity of Ag NPs, it is difficult to know for certain, 
whether the nanomaterial toxicity is mainly due to the release of metal ions or if an 
alternative mechanism exists. 
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OBJECTIVES OF THE STUDY 
As is evident from the literature, NPs find immense applications in almost every field 
including cosmetics, electronics, medical diagnosis and therapeutics, etc. The 
widespread production and utilization of CuO and Ag NPs may therefore, increase the 
likelihood of their exposure, posing potential health risks. So, toxicity evaluation of 
these NPs should be thoroughly conducted in order to have their continued, safe and 
effective use. In the present study, we have made an attempt to use relatively simple, 
sensitive, rapid and reliable assays to assess the potential hazardous effects of these 
NPs. The detailed objectives of the study are given below: 
1. Phytotoxicity assessment of selected NPs employing seed germination assay 
using com, cucumber and moong seeds and determination of their IC50 values. 
Seed germination test has been recommended as a part of level I terrestrial 
environmental assessment using biological tests (Brusick and Young, 1981). 
2. DNA binding studies with CuO and Ag NPs using spectrophotometric and 
spectrofluorimetric analyses. 
3. Genotoxicity evaluation using comet assay for detecting DNA damage in 
human peripheral lymphocytes exposed to different concentrations of test NPs. 
4. Cytotoxicity assessment of CuO and Ag NPs by means of hemolytic assay 
with human RBCs. 
5. Assays of some enzymatic and non-enzymatic antioxidants in the hemolysates 
prepared after treatment with the above mentioned NPs, as various 
components of detoxification machinery have been shown to get modulated 
after exposure to certain NPs (Hussain et al., 2005; Fahmy and Cormier, 
2009). 
6. Estimation of in vitro ROS generation by the selected NPs. Since, toxicity of 
many NPs has been reported to be mediated by reactive oxygen species 
(Asharani et al., 2009), their pattern can also serve as a fingerprint of the NPs 
and their toxicity. 
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Cfiapter 11: 
Materials ancCMetfiods; 
Cfiaracterization of SeCectecC MPs 
MATERIALS: 
The NPs of copper oxide (CuO) and silver metal (Ag) were obtained from and 
characterized in 'Centre of Excellence in Material Science (Nanomaterials). A.M.U.. 
Aligarh'. Other chemicals used in the study along with their sources are listed below: 
Chemicals 
5,5'-Dithiobis-(2-nitrobenzoic acid) 
Agarose 
Bovine serum albumin 
Calf thymus DN A 
Cupric sulphate 
Dextrose 
di-Sodium hydrogen orthophosphate 
Ethidium bromide 
Ethylene-diammine-tetra-acetic acid 
Folin-Ciocalteau reagent 
Heparin 
Histopaque 1077 
Horse radish peroxidase 
Hydrochloric acid 
Hydrogen peroxide 
Low melting agarose 
Nitro blue tetrazolium chloride 
pBR322 plasmid DNA 
Phenol red 
Potassium chloride 
Potassium dihydrogen orthophosphate 
Potassium phosphate dibasic 
Pyrogallol 
RPMI-1640 medium 
Seeds (com, cucumber and moong) 
Sodium carbonate 
Sources 
Sisco Research Laboraties. India 
Sisco Research Laboraties, India 
Sisco Research Laboraties, India 
Sisco Research Laboraties. India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals. India 
Qualigens Fine Chemicals. India 
Hi Media Laboratories Pvt. Ltd., India 
Sisco Research Laboraties. India 
Sisco Research Laboraties, India 
Sisco Research Laboraties, India 
Sigma Chemical Co., USA 
Sisco Research Laboraties, India 
Merck Specialities Pvt. Ltd.. India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Sisco Research Laboraties, India 
Genei, India 
Sisco Research Laboraties, India 
Qualigens Fine Chemicals. India 
Sisco Research Laboraties. India 
Sisco Research Laboraties, India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Local market 
Sisco Research Laboraties, India 
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Sodium chloride 
Sodium dihydrogen orthophosphate 
Sodium hydroxide pellets 
Sodium potassiimi tartarate 
Succinic acid 
Sulphosalicylic acid 
Thiobarbituric acid 
Trichloro-acetic acid 
Tris (hydroxymethyl) amino methane (base) 
Tris (hydoxymethyl) amino methane hydrochloride 
Triton-X-100 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Hi Media Laboratories Pvt. Ltd., India 
Qualigens Fine Chemicals, India 
sd-Fine Chem. Ltd, India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sisco Research Laboraties, India 
Sisco Research Laboraties, India 
Loba Chemie Pvt. Ltd., India 
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METHODS 
1. Characterization of nanoparticles 
The pre-synthesized nanoparticles of CuO and Ag were characterized using 
transmission electron microscopy (TEM), X-ray diffraction (XRD) analysis and 
fourier transform infrared specfroscopy (FTIR). The morphology and size of the 
nanoparticles were investigated by means of transmission electron microscopy. TEM 
micrographs of the samples were taken using JEOL 2100 F instrument. Crystalline 
structure of the samples were determined by XRD technique using a Rigaku Miniflex 
X-ray diffractometer at a scanning rate of 4 min"', in 20 range of 5-85°. FTIR spectra 
were obtained using a Perkin Elmer (Spectrum-II) spectrophotometer, with wave 
numbers in the range of 4000 - 400 cm''. 
Transmission electron microscopy (TEM) was carried out to analyze the shape and 
size of CuO and Ag NPs (Figure 1). CuO NPs were found to have a size range of 153-
162 nm, whereas, Ag NPs exhibited size of 30.3-41.8 nm range. Moreover, both the 
NPs were foimd to be roughly spherical in shape. 
The X-ray diffraction (XRD) analysis of CuO NPs was carried out to check the purity 
of the particles. The diffraction peaks obtained at 31.71°, 34.91°, 37.90°, 48.13°. 
52.61°, 57.52°, 60.93°, 65.62°, 67.32°, 71.41° and 74.25°, are shown in Figure 2(a) and 
it confirms the synthesized CuO NPs to be free from impurities, as it does not contain 
any characteristic XRD peak other than CuO peaks. Similar were the observations of 
Rahman et al. (2009) and Krithiga et al. (2013). The crystal size of CuO NPs as 
calculated from the spectra was found to be 21.1 nm. 
Figure 2(b) presents the typical XRD pattern of Ag NPs. The spectrum shows the 
diffraction peaks at 27.0°, 31.3°, 35.14°, 45.46°, 54.09°, 56.49° and 75.69°. No other 
peaks of impurities have been detected confirming the synthesized nanoparticles to be 
pure. Similar spectra were obtained in previous studies by other researchers (Selvi and 
Sivakumar, 2012; Mani et al., 2013). The average crystal size of Ag NPs was found to 
be 25.4 nm. 
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FTIR spectrometry was done to check the purity of the pre-synthesized NPs of CuO 
and Ag, Figure 3(a) shows the IR-spectra of CuO NPs in the range of 4000-400 cm"'. 
The peaks observed in the spectrum at 2926.88 cm'' and 527.94 cm"' are assigned to 
C-H stretch (alkanes) and Cu-0 stretch respectively, confirming the formation of pure 
CuO NPs. Similar were the observations of Azam et al. (2012) and Krithiga et al. 
(2013). 
FTIR spectrum of Ag NPs is shown in Figure 3(b). The band positions at 2915.68 cm-
1 and 1303 cm-1 correspond to the vibrations of alkanes (C-H stretch) and 
alcohols/esters/ethers (C-0 stretch) respectively. Moreover, the peaks at 1015.73 cm-
1 and 795.0 cm-1 are attributed to the vibrations of C-0 (alcohols/esters/ethers) and 
=C-H (bend) respectively. Previous studies done by Mani et al. (2013) showed similar 
band postions. 
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Fig. 1: TEM micrographs of (A) CuO and (B) Ag nanoparticles 
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2. Toxicity Assays 
2.1. Seed Germination Assay 
The seed germination test was carried out as described by Wang (1987) with 
the modification of Dutka (1996) to suit the local conditions. The seeds of 
com {Zea mays), cucumber (Cucumis sativus) and moong (Phaseolus radiata) 
were selected for the present study. 
2.1.1. Requirements for seed germination test 
• Locally available varieties of seeds of com, moong and cucumber. 
• Petri plates of size 100 x 15 mm. 
• Whatman No. 1 filter paper. 
• 0.02% sodixmi hypochlorite / 0.01% mercuric chloride solution which 
were used for surface sterilization of seeds. 
• Different concentrations of nanoparticle suspension and their respective 
ionic solutions prepared in distilled water. 
2.1.2. Exposure of seeds to nanoparticles 
The seeds were first washed with 0.01% mercuric chloride solution and then 
repeatedly washed with distilled water. They were then briefly placed on a 
filter paper to dry. A double layer of Whatman filter paper was placed on the 
petridishes and 6 ml of each concentration of the sample was added. 
Aquaguard water was used as control. 20 seeds were then put on each 
petridish, suitably separated from each other and the plates were then kept in 
dark for 5 days, maintaining the temperature at 25±5 °C. Small volume (3-4 
ml) of samples was poured on to the seeds after every 10-12 hours to keep 
them wet. 
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2.1.3. Determination of ICso values 
After the incubation is complete, root lengths of the germinated seeds were 
measured and percent inhibition for each concentration of sample was 
calculated using the following formula: 
Root length in control - Root length in sample 
% inhibition = x 100 
Root length in control 
Percent inhibition versus sample concentration curve was then plotted and IC50 
value was calculated from the plot. IC50 is defined as the sample concentration 
at which 50% root inhibition is obtained with respect to control. 
2.2. Nanoparticle - DNA Interaction Study 
The interaction of NPs with calf thymus DNA was checked by the following 
techniques: 
2.2.1. UV-Vis Spectrophotometric Analysis 
The UV absorption spectra of calf thymus DNA solution were analyzed by the 
method of Rahban et al. (2010) in the range of 240-300 nm using UV-1700 
spectrophotometer (Shimadzu, Japan). Spectral changes in 7 mM DNA were 
monitored upon addition of different concentrations of NPs (0-100 ppm). All 
experiments were performed in Tris-base buffer (0.1 M, pH 7.5), in 
conventional quartz cell and the temperature was maintained at 37 °C. 
2.2.2. Spectrofluorimetric Analysis 
The fluorescence of ethidium bromide (EtBr) is greatly enhanced upon 
intercalation between the base pairs of DNA. EtBr displacement assay was 
performed by the method of Rahban et al. (2010). Firstly, DNA (80 ^M, in 0.1 
M Tris-buffer, pH 7.5) was added to aqueous EtBr solution (0.1 mg/ml), and 
471 nm wavelength was selected as the excitation radiation for the samples at 
37 °C in the range of 480-720 nm. To this solution (containing EtBr and 
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DNA), different concentrations of NPs (0-100 ppm) were added. 
Measurements were done using spectrofluorometer (Shimadzu, Japan) at 1 cm 
path length. 
2.3. Comet Assay (Single cell gel electrophoresis) 
Comet assay was performed under alkaline conditions according to the 
procedure of Singh et al. (1988) with slight modifications to suit our 
experimental conditions. The details are given below: 
2.3.1. Isolation of lymphocytes 
Heparinized blood sample was obtained from a single healthy volunteer (self 
donor) and diluted suitably in saline. Lymphocytes were isolated from blood 
using Histopaque 1077 and the cells were finally suspended in saline. 
2.3.2. Experimental procedure 
Fully frosted microscopic slides were first coated with 1.0% normal melting 
agarose. Diluted lymphocytes were then mixed properly with equal volume of 
2.0% low melting agarose and half of the mixture was pipetted over the first 
layer. The slides were then covered immediately by cover slips and placed on 
ice for 15 min to solidify the layer. After removing the cover slips, cells were 
treated with increasing concenfrations of samples (0-500 ppm) for 1 hour at 
4°C. Lysis was done in cold lysis solution followed by unwinding of DNA for 
30 min in alkaline elecfrophoretic solution. Electrophoresis was performed at 
4°C and DNA were neutralized in neutralization solution. The slides were then 
stained with EtBr, washed with distilled water, covered with cover slips and 
placed in a humidified chamber. 
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2.3.3. Visualization of slides and scoring 
Slides were visualized and scored using an image analysis system (Komet 5.5; 
Kinetic Imaging, Liverpool, UK) attached to an Olympus (CX41) fluorescent 
microscope (Olympus Optical Co., Tokyo, Japan) and a COHU 4910-
integrated CC camera (equipped with 510-560 nm excitation and 590 nm 
barrier filters) (COHU, San Diego, USA). Images fi-om 50 cells (25 from each 
replicate slide) were analyzed. Tail length (migration of DNA from the 
nucleus, in jjm) was chosen as the parameter to assess DNA damage. 
2.4. Hemolytic Assay 
2.4.1. Isolation of erythrocytes from human blood 
Heparinized fresh human blood (self donor) was taken from young (22-30 
years), healthy and non-smoking individual. It was centrifiiged at 1,500 rpm 
for 10 min at 4 °C in a clinical centrifuge and the plasma and buffy coat were 
removed by aspiration. The erythrocyte pellet was washed thrice with 
phosphate buffered saline (PBS) (0.01 M phosphate buffer, 0.9% NaCl, pH 
7.2) and resuspended in PBS to give a 5% hematocrit. 
2.4.2. Treatment of erythrocytes with different concentrations of nanoparticle 
suspensions and preparation of lysates 
Erythrocytes were incubated with increasing concentrations of NPs (0-800 
ppm) for 1 hour at 37°C. Untreated erythrocytes served as control and 
similarly incubated at 37°C for 1 hour. The treated RBCs were centrifuged at 
2,500 rpm for 10 min at 4°C. Supematants were collected and their absorbance 
recorded at 540 nm. The erythrocyte pellets were washed thrice with PBS and 
cells were lysed with 10 volumes of 5mM sodium phosphate buffer at 4°C for 
2 h. The samples were centrifuged at 3000 rpm for 10 min at 4°C and the 
supematants (hemolysates) were quickly frozen in aliquots and later used for 
the analysis of several biochemical parameters. Untreated erythrocytes, not 
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incubated at 37°C were completely lysed with distilled water and used as 
reference. 
2.4.3. Determination of total protein concentration 
The total protein content in the hemolysates was determined by the Folin's 
reagent using bovine serum albumin as standard (Lowry et al.,1951). This 
method is based on the reactivity of peptide nitrogen[s] wdth the copper [11] 
ions under alkaline conditions and the subsequent reduction of 
phosphomolybdate-phosphotungstic acid (present in Folin's reagent) to 
heteropolymolybdenum blue by the copper-catalyzed oxidation of aromatic 
acids (Dunn, 1992). 
2.4.4. Assay of enzymatic and non-enzymatic antioxidants 
2.4.4.1. Superoxide dismutase (SOD) 
SOD activity in the hemolysate was assayed by measuring its ability to 
inhibit the autooxidation of pyrogallol according to the method of 
Marklund and Marklund (1974). To 50 i^ l of hemolysate, 2.85 ml of Tris 
succinate buffer (0.05 M, pH 8.2) was added and the reaction was started 
by adding 100 \i\ of 8.0 mM pyrogallol. The change in absorbance was 
recorded at an interval of 30 sec for 3 min at 412 nm. A reference set 
containing 50 i^l distilled water instead of sample, was also run 
simultaneously. The activity was reported in terms of U/mg protein. 
2.4.4.2. Catalase (CAT) 
Catalase activity was measured in terms of decrease in H2O2 concentration 
according to the method of Claibone (1985). The assay mixture contained 
0.05 M potassium phosphate buffer (pH 7.0), 0.03 M hydrogen peroxide 
solution and 0.02 ml hemolysate in a final volume of 3 ml. The decrease in 
absorbance was noted after every 30 sec for 3 min. Enzyme activity was 
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calculated using the molar extinction coefTicient of H2O2 and reported in 
U/mg protein. 
2.4.4.3. Reduced glutathione (GSH) 
GSH in hemolysate was determined spectrophotometrically by the method 
of Jollow et al. (1974). Proteins present in hemolysates were first 
precipitated with 4% sulpho-salicylic acid and the mixture was centrifuged 
at 12,000 rpm for 15 min at 4°C. 0.4 ml of supernatant was then mixed 
with 2.2 ml of potassium phosphate buffer (0.1 M, pH 7.4) and 0.4 ml 
DTNB (4 mg/ml) and the yellow colour was read at 412 nm. The method 
is based on the reduction of 5,5'-dithiobis-(2-nitrobenzoic acid) by the -
SH groups of GSH in alkaline medium to produce 2-nitro 5-
mercaptobenzoic acid. The concentration was reported in terms of 
nmole/mg protein. 
2.4.4.4. Lipid peroxidation (LPO) 
The extent of membrane lipid peroxidation was determined from 
malondialdehyde (an end product of LPO) content by the method of Beuge 
and Aust (1978). 1.0 ml of hemolysate was mixed with 2.0 ml of TBA-
TCA-HCl reagent and the mixtiu-e was heated in boiling water bath for 15 
min. After cooling to room temperature, the precipitate was removed by 
centrifugation at 4000 rpm for 10 min and absorbance of supernatant was 
recorded at 535 nm against a blank that contains all the reagents except 
hemolysate. The MDA concentration was calculated using a molar 
extinction coefficient of 1.56 x 10^  M"'cm"' and reported in nmole/mg 
protein. 
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2.5. Estimation of ROS generation by the test samples 
2.5.1. Superoxide radicals 
The estimation of "Oi was done by NBT-"02 determination method of 
Nakayama et al. (1983). The reaction mixture contained 300 i^ l of sodium 
phosphate buffer (100 mM, pH 8.0), 100 i^l of NBT (1.0 mM), 300 [x\ of 
triton-X-100 (0.6%), 2.2 ml of distilled water, and different concentrations of 
samples (0-500 ppm). Absorbance was taken at 560 nm. 
2.5.2. Hydroxyl radicals 
The estimation of OH radical was done by the method of Richmond et al. 
(1981). To different concentrations of test samples, 150 ^1 of Tris-HCl buffer 
(0.01 M, pH 7.5) and 300 ^l of calf thymus DNA (3.0 mM) were added, and 
the mixture was incubated for 1 hr at 37 °C. This is followed by the addition of 
1.2 ml of 28% TCA, to stop the reaction. After that 1.2 ml of 1% TBA was 
added and test tubes were boiled for 15 min. After cooling the test tubes to 
room temperature, absorbance was recorded at 532 nm. 
2.5.3. Hydrogen peroxide 
The amount of hydrogen peroxide (H2O2) generated by the NPs was estimated 
by the horse radish peroxidase (HRPO)-mediated oxidation of phenol red by 
H2O2 (Pick and Keisari, 1980). The reaction mixtures containing 2.8 ml 
phenol red (0.28 mM phenol red, 20 Uml'' HRPO, 5.5 mM dextrose, 10 mM 
potassium phosphate buffer, pH 7.0), 100 ^1 of NaOH (IN) and different 
concentrations of test samples were incubated at 37 "C for 10 min in fiilly 
covered tubes. At the completion of incubation, the mixture was centriftiged at 
2,500 rpm for 5 min at 4 "C and absorbance of the supernatant was taken at 
610 nm. 
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3. Statistical Evaluation 
Data was expressed as Mean ± S.D. of six different values and analyzed by one-way 
ANOVA. Differences among controls and treatment groups were determined using 
Student's t-test. P values of less than 0.05 were considered statistically significant. All 
comparisons were made with untreated control. 
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chapter III: 
^ResuCts 
Germination-inhibition profiles of three types of seeds (com, cucumber and moong) 
following increasing treatment with CuO and Ag nanoparticles and their respective 
ionic forms are shown in Figure 1. Percent inhibition in root growth in general 
increased with increase in concentrations of test samples. The seeds of cucumber were 
recorded to be most sensitive towards the toxic effect of all the test samples except 
CuO NPs. For these NPs, cucumber seeds were least sensitive while the seeds of com 
exhibited the highest susceptibility. The IC50 values of CuO and Ag NPs, and their 
respective ions, along with the senshivity pattern of different seeds are given as under: 
CuO NPs: Com (175 ppm) > Moong (185 pm) > Cucumber (460 ppm) 
Ag NPs: Cucumber (560 ppm) > Com (640 ppm) > Moong (670 ppm) 
CuCh salt: Cucumber (35 ppm) > Com (60 ppm) > Moong (56 ppm) 
AgNOs salt: Cucumber (52 ppm) > Com (75 ppm) > Moong (110 ppm) 
Nanoparticles of CuO exhibited greater phytototxic effects than those of Ag metal. 
Moreover, the ionic forms were found to be more phytotoxic than the respective nano 
forms. 
Figures 2 and 3 present the changes in UV absorption spectra of calf thymus DNA at 
37°C, upon addition of increasing concentrations of CuO and Ag nanoparticles 
respectively. A dose-dependent increase in the absorption intensity at 260 nm was 
observed with CuO NPs but not with Ag NPs, where intensity decreased with increase 
in concentration. The changes occurring in absorption spectra suggest that both the 
nanoparticles were able to interact with calf thymus DNA. 
Figures 4 and 5 depict the variation in fluorescence emission spectra of ethidium 
bromide (EtBr) bound calf thymus DNA upon addition of increasing concentrations 
of CuO and Ag nanoparticles. A dose-dependent reduction in fluorescence intensity 
was observed in both the cases, suggesting the displacement of EtBr with the test 
nanoparticles. 
The comet assay images of DNA damage in human lymphocytes in the presence of 
different concentrations of CuO and Ag NPs and their ionic forms, as observed under 
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an optical fluorescent microscope are shown in Figure 6. The graphical representation 
of data is given in Fgure 7. It is clear from the images and the graphs that increase in 
concentration of test NPs resulted in the DNA damage. Thus, both the substances in 
nano as well as ionic forms seemed to have induced a dose-dependent damage in 
human lymphocyte DNA. However, CuO NPs were more genotoxic as compared to 
Ag NPs in terms of DNA tail length. Moreover, ionic forms resulted in a greater level 
of damage than their respective nano forms. 
Hemolytic assay was performed with human erythrocytes at increasing concentrations 
of both the nanoparticles to assess their cytotoxic activitites. Figure 8 presents the 
relative rates of hemolysis at different concentrations of test nanoparticles. A dose-
dependent increase in percent hemolysis was observed with both the nanoparticles, 
suggesting them to possess cytotoxic activity. However, CuO NPs were found to be 
more cytotoxic resulting in 83.3% hemolysis at 800 ppm concentration, as compared 
to Ag NPs causing 75.6% hemolysis at the same concentration. 
Figure 9 shows the pattern of SOD activity observed in the hemolysates after treating 
the RBCs with increasing concentrations of CuO and Ag NPs. The activity showed a 
decline in a dose-dependent manner upon treatment with both the nanoparticles. The 
decline in SOD activity with respect to control at 800 ppm concentration of CuO and 
Ag NPs were measured to be 76.9% and 62.4% respectively. 
The conversion of hydrogen peroxide to water is catalysed by the enzyme CAT. 
Figure 10 depicts the levels of CAT activity in the hemolysates as a result of exposure 
to increasing concentrations of both the nanoparticles. A decrease in the activity was 
observed with the increase in concentration of CuO as well as Ag NPs. Exposure to 
800 ppm of Ag NPs resulted in 87.8% decrease in CAT activity with respect to 
control. However, CuO NPs at the same concentration brought about a decline of only 
41.0% in CAT activity. 
The change in concentration of GSH in the hemolysates after treatment with different 
concentrations of CuO and Ag NPs is depicted in Figure 11. Increasing concentrations 
of both the NPs had only a small effect on GSH level. Treatment of RBCs with CuO 
NPs resulted in a dose-dependent reduction in GSH concentration with a decline by 
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16.5% at 800 ppm concentration. Contrary to that, exposure of RBCs to Ag NPs at 50 
ppm concentration raised the GSH level by 11.5%. Exposure at higher concentrations 
of this NP, however, resulted in small reduction in GSH level with respect to control 
albeit not exceeding to 6.3% at 800 ppm. 
The effects of increasing concentrations of CuO and Ag NPs on the extent of LPO, 
measured in terms of MDA level are shown in Figure 12. Both the NPs resulted in a 
dose-dependent rise in the MDA content. A 50.0% increase in the level was observed 
in the hemolysates prepared after treatment with 800 ppm concentration of Ag NPs. 
However, with the same concentration of CuO NPs, there was an increase by 71.4%. 
Figures 13-15 depict the pattern of in vitro ROS generation by CuO and Ag NPs as 
well as their respective ionic forms. All the three species i.e. superoxide radicals, 
hydroxy 1 radicals and hydrogen peroxide were shown to be generated at higher levels 
by CuO NPs as compared to those produced by Ag NPs i.e. CuO NPs were able to 
generate 49.6%, 41.8% and 48.4% geater superoxide radicals, hydroxyl radicals and 
hydrogen peroxide, respectively. Moreover, the ionic forms were able to produce 
much greater amounts of ROS than their respective nano forms. 
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Fig. 4: Fluorescence spectra of DNA-EtBr complex in presence of 
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Fig. 6: Single cell gel electrophoretic images of human peripheral lymphocytes: 
(A) untreated (control), and treated with 500 ppm of: (B) CuO NPs, 
(C) Ag NPs, (D) CuCk salt, (E) AgNOa salt 
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chapter TV: 
Discussion 
Nanotechnology has brought a new technological revolution that concerns almost 
every aspect of human life. Due to the smaller dimensions, NPs exhibit properties 
different from their bulk counterparts. They possess unique physicochemical, optical, 
electrical and biological properties that can be exploited suitably for desired 
applications (Feynman, 1991). They are currently being used in various fields 
including medical diagnostics, therapeutics, cosmetics, electronics, etc. In particular. 
CuO NPs due to their fascinating properties possess photoconductive and 
photothermal applications (Rakhshani, 1986). Ag NPs on the other hand, find 
immense applications as a medium for antibiotic delivery; as anti-bacterial agents in 
food storage, textiles and various personal care products (Stensberg et al., 2011); and 
in the synthesis of composites used for disinfecting filters and coating materials (Li et 
al., 2005; Kim et al., 2007). 
Due to the increasing production and utilization of these NPs, and growing likelihood 
of their occupational and environmental exposure, concerns are being raised over their 
potential harmfiil effects to humans and environment (Benn et al., 2010). In the 
present study, we made an attempt to evaluate the potential toxic effects of CuO and 
Ag nanoparticles using a battery of toxicity assays including phytotoxicity, 
genotoxicity and cytotoxicity tests. 
Plants have been employed for toxicity assays but not as extensively as animals 
(Biney, 1991). The test for inhibition of seed germination and root elongation has 
been used to screen the plants for heavy metals, salinity and mineral stress, to 
determine the selective toxicities of herbicides, and evaluate the toxic chemicals 
(Ratsch and Johndro, 1986). This test has been recommended as a part of level I 
terrestrial environmental assessments using biological tests (Brusick and Young. 
1981). Moreover, it has also been used extensively to study the toxicity of 
nanoparticles (Dimkpa et al., 2012; Tang et al., 2012; Lee et al., 2013). 
Seed germination test is a short-term, root growth inhibition test making use of locally 
available seeds of cabbage, cucumber, moong, radish, com, rye, millet, etc. The 
inhibition of root growth in these seeds as a result of their exposure to test samples 
with respect to control (tap water) is an indicator of toxicity of the test substance, 
whereas, percentage of inhibition in root growth following soaking the seeds with 
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varying concentrations of test samples is an index of toxicity. The higher the degree 
of toxicity, the greater is the inhibition in root length. IC50, an index of toxicity, is 
defined as the concentration of the toxicant that results in 50% inhibition of root 
growth with respect to control (Sebaugh, 2011). 
Among various seeds selected for the present study, seeds of Cucumis sativus 
(cucumber) showed maximum sensitivity towards all the test samples excluding CuO 
NPs, and Phaseolus radiata (moong) seeds were foimd to be least sensitive under our 
experimental conditions. Similar were the findings of Kumari et al. (2012) for 
cucumber and com seeds in presence of Ag NPs. Maximum inhibitory response for 
CuO NPs has been shown by Zea mays (com), whereas, cucumber seeds were found 
to be least responsive towards CuO NPs. Further, both the NPs as well as their ionic 
forms resulted in a dose-dependent inhibition of seed germination, and were therefore, 
found to be remarkably phytotoxic. A dose-dependent phytotoxicty of CuO and Ag 
NPs has also been shown by Salama et al. (2012) and Wu et al. (2012) respectively. 
As is evident from Figure 1, inhibition was more with CuO NPs than with Ag NPs at 
the same concentration, suggesting CuO NPs to possess greater phytotoxic potential. 
Furthermore, ionic forms were found to be more phytotoxic than their respective nano 
forms. The presence of cell wall may act as a barrier for the entry of nanoparticles 
into the cells and thus, only a few of these particles would penetrate the plant cell wall 
to cause the phytotoxic effect. 
In order to check the mode of interaction of nanoparticles with calf thymus DNA, 
spectroscopic analyses were carried out. In general, hyperchromism and 
hypochromism brought about by the test sample reflect the spectral features of the 
changes in the double-helical stmcture of DNA. Hyperchromism indicates a distortion 
in the secondary stmcture of DNA, whereas, hypochromism usually depicts the 
intercalation or electrostatic interaction of the test sample with DNA (Rahban et al., 
2010). UV absorption spectra of DNA in presence of increasing concentrations of 
CuO and Ag NPs (25-200 ppm) at 37 °C are shown in Figures 2 and 3. The changes 
observed in the absorption intensity of calf-thymus DNA at 260 nm, might be the 
result of nanoparticle binding to DNA causing stmctural changes including local 
unwinding or compaction (Zhang et al., 2011; Railsback et al., 2012; Li et al., 2013). 
It has been reported that nanoparticles can bind to DNA through a combination of 
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electrostatic interaction and groove binding (Railsback et al., 2012). Thus, spectral 
analysis revealed quite a strong interaction of nanoparticles with calf thymus DNA. 
Competitive EtBr binding studies or EtBr displacement assays have been done to 
determine the extent of binding of CuO and Ag NPs with DNA. This is a well known 
fact that the fluorescence intensity of EtBr enhances when it goes from a polar to a 
nonpolar medium because of a decrease in the intersystem crossing lifetimes (Krishna 
et al., 1998). The molecular fluorophore EtBr, a phenenthridine fluorescence dye. 
itself does not show any significant emission, due to the quenching of free EtBr by 
solvent molecules. However, upon addition of DNA, its fluorescence intensity is 
greatly enhanced as a result of strong intercalation of the planar phenenthridinium 
ring between adjacent base pairs of DNA (Butour and Macquet, 1997). The 
displacement of DNA intercalated EtBr by groove binding molecules has been used as 
a standard technique to assay DNA binding agents (Sambrook, 1989). The decrease in 
fluorescence intensity of DNA-EtBr complex in presence of increasing concentrations 
of CuO and Ag NPs is shown in Figiu-es 4 and 5. The quenching of fluorescence 
intensity indicates the binding of NPs to DNA, causing either replacement of bound 
fluorophore or promoting a conformation incompatible to EtBr binding, as observed 
by Goodman et al. (2006) upon interaction of gold NPs with EtBr bound DNA. 
Rahban et al. (2010) used Ag NPs in their EtBr displacement assay and obtained 
similar results. Like those of absorption spectroscopic analyses, these results 
unequivocally suggest the interaction of NPs with calf-thymus DNA. 
Single cell gel electrophoresis (also known as comet assay) is a commonly used 
genotoxicity test for various substances present in the environment, as it is relatively 
easy to handle and can be applied to cells from different organisms and tissues 
(Vnenchak and Rokosz, 1997; Tice et al., 2000). Alkaline version of the assay was 
developed by Singh et al. (1988). Several studies have assessed the level of DNA 
damage by means of comet assay (Karlsson et al., 2008; Cho et al., 2013; Gomes et 
al., 2013). Present study has also employed this assay to test the genotoxic potential of 
CuO and Ag NPs and their respective ions. A significant dose-dependent increase in 
DNA damage has been observed in human lymphocytes with respect to control, upon 
exposure to test samples, confirming their genotoxic potential (Figure 6). This is in 
accordance with the previous studies on genotoxicity of CuO and Ag NPs and their 
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respective ionic forms (Gomes et al., 2013). DNA damage was measured in terms of 
tail length and that was shown to increase with increasing concentrations of test 
samples (Figure 7). The experiment is based on the ability of a genotoxic substance to 
cause single or double strand nicks in the DNA that would lead to the formation of 
DNA fragments, which under an electric field migrate away from the nucleoid core 
(also known as comet head). Distance travelled by the broken DNA from the nucleoid 
core is known as tail length, which is one of the DNA damage parameters in case of 
comet assay. Thus, greater the genotoxicity of a compound, higher will be the degree 
of DNA strand breaks and therefore, more will be the distance travelled by the 
damaged DNA resulting in greater value of tail length. 
In the present study, the extent of DNA sfrand breakage was found to be greater with 
CuO NPs confirming them to be more genotoxic than Ag NPs. Moreover, the ionic 
forms were found to be more genotoxic than the respective nano forms, resuhing in 
about 20% greater tail length values. It has already been suggested that both CuO and 
Ag NPs enter the cell and generate radicals that interfere with the cellular metabolic 
activities, eventually leading to DNA damage (Karlsson et al., 2008; Asharani et al., 
2009; Bhatt and Tripathi, 2011; Gomes et al., 2011). Further, both the NPs may also 
cause induction of mitochondrial dysfiinction as well as oxidative sfress that may also 
damage DNA (e.g. Asharani et al., 2009; Manna et al., 2012). Based on the present 
and previous findings, it can be proposed that DNA damage seen in human 
lymphocytes upon exposure to test samples might be the result of induction of 
oxidative stress. 
Cytotoxic effects of various environmental substances are usually being estimated by 
means of hemolytic assay (Yu et al., 2011; Oves et al., 2013). Hematological studies 
are of ecological and physiological interest as they help in understanding the 
relationship of blood characteristics to the environment (Boge and Roche, 2004; 
Ovuru and Ekweozor, 2004). In this study, the toxic effects of CuO and Ag NPs have 
been investigated on human erythrocytes; and a dose-dependent increase in the 
relative rates of hemolysis has been observed (Figure 8). However, CuO NPs were 
found to be slightly more cytotoxic than Ag NPs, resuhing in about 8% higher 
hemolysis at 800 ppm concentration. The increase in hemolysis with increasing 
nanoparticle concentration might be the result of direct and indirect injury to the cells. 
-57-
Thus, mechanical injury as well as enhanced production of free radicals upon 
exposure to either of the NPs would be responsible for hemolysis. Moreover, NPs are 
known to release respective ions from their surface as a ftinction of particle surface 
area (Lansdown, 2010) that are also supposed to cause RBC hemolysis (Ballinger et 
al., 1982). 
Reactive oxygen intermediates (ROIs) are normally produced by living organisms as 
a result of various metabolic activities. Low concentrations of these chemicals are 
important as they function in physiological processes of different cells, but at high 
concentrations, they may damage various cellular components, such as lipids, 
proteins, and DNA (Siems et al., 1995; Wang et al., 1996; Halliwell and Gutteridge, 
1999; Mamett, 1999; Stadtman, 2004; Valko et al., 2006). On the other hand, human 
body contains a variety of enzymatic as well as non-enzymatic antioxidants that 
counterbalance the effects of these oxidants. Thus, a balance should be maintained 
between the level of ROIs and antioxidants in order to prevent the induction of 
oxidative stress. The three major ROS that are of physiological significance include: 
superoxide radicals ('O2), hydroxyl radicals ('OH) and hydrogen peroxide (H2O2). 
Primary biochemical components of oxidative stress response include elevation of 
LPO, suppression of GSH, and alteration of the activities of antioxidant enzymes. A 
major cellular defense against ROS is provided by SOD and CAT, which together 
convert superoxide radicals first to H2O2 and then to molecular oxygen and water 
(Alavarez and Lamb, 1997). 
Since superoxide is the primary ROS produced from a variety of sources, its 
dismutation by SOD is important for each cell. SOD is called the first line of defense 
against ROS generation because superoxide radical is a precursor to several other 
highly reactive species (Hassan and Scandalios, 1990; Briganti and Picardo, 2003: 
Sezer et al., 2007). It naturally exists in three forms, out of which, Cu/Zn-SOD and 
Mn-SOD are considered as bulk scavengers of superoxide radicals and are shown to 
be involved in the regulation of oxidative stress (Azevedo et al., 1998; Kliebenstein et 
al., 1998). In the present investigation, a dose-dependent decrease in SOD activity 
with respect to control has been observed in the hemolysates, prepared after treatment 
with both the NPs (Figure 9). However, CuO NPs exhibited 39% greater reduction 
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than Ag NPs at 800 ppm concentration. These findings were consistent with those of 
Devipriya et al. (2007) and SchJorff et al. (1999). They have also observed a dose-
dependent decrease in SOD activity in presence of NPs. The activity reduction is 
presumably because of the replacement of metal ions from enzyme's active site by the 
ions released from the NPs, resulting in their inactivation (Leite et al., 2014). 
Catalases and peroxidases are the major enzymes involved in H2O2 detoxification. 
Figure 10 shows a dose-dependent decline in CAT activity in the hemolysates upon 
incubation with increasing concentrations of CuO and Ag NPs. Our findings are 
consistent with those of Rani et al. (2013), showing similar effects of CuO NPs on 
CAT activity. Moreover, it has also been observed that Ag NPs exhibited 79% greater 
reduction in the enzyme activity as compared to CuO NPs. The reason for this decline 
in CAT activity might be either the nominal increase in H2O2 as a result of Ag NPs 
exposure to RBCs or their consumption in Fenton reactions (Gomes et al., 2012). 
GSH is considered as one of the most potent antioxidants that is involved in 
quenching the oxyradicals; thus, maintaining the redox status of the cells (Ross, 
1988). It is the key non-enzymatic antioxidant of the cell that serves as the substrate 
for H2O2 scavenging enzymes namely GPx, where it is converted to its oxidized form, 
and therefore, needs to be recycled back. Decrease in intracellular GSH concentration 
upon exposure to some NPs has been reported by many investigators (Hussain et al., 
2005; Ahamed et al., 2010). Our findings are at variance with them, as we recorded an 
insignificant decline in GSH level in the hemolysates prepared after exposure to 
increasing concentrations of CuO and Ag NPs (Figure 11). Rather, upon treatment 
with 50 ppm concentration of Ag NPs, the level initially enhanced by 11.5%, with 
further increase in concentration, it started decreasing. The levels are supposed to be 
suppressed under severe oxidative stress due to the loss of compensatory responses 
and oxidative conversion of GSH to its oxidized form (Chen and Lin, 1977; Ahamed 
etal.,2010). 
Lipid peroxidation is a free radical-mediated chain reaction, that is self-perpetuating; 
and the length of the chain propagation depends upon the antioxidant enzymes 
(Harris, 1992). It is measured in terms of the concentration of MDA, a product of 
LPO. In the present study, exposure of RBCs to increasing concentrations of CuO and 
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Ag NPs resulted in a dose-dependent elevation of MDA level in the hemolysates 
(Figure 12). These results are supported by the previous findings showing increment 
in MDA level in presence of CuO NPs (Ahamed et al, 2010). Moreover, as compared 
to Ag NPs, CuO NPs exhibited significantly greater level of lipid peroxidation, 
producing about 19% higher amount of MDA at maximum concentration (i.e. 
800 ppm). Increase in MDA level has also been reported in various mammalian 
tissues during oxidative stress and has generally been used as a marker of oxidative 
stress (Hussain et al., 2001; Jadhac et al., 2007a, b). 
In a nutshell, present results of oxidative stress markers demonstrate significant 
decline in the levels of antioxidant enzymes (SOD and CAT) and elevation in LPO 
level, as a result of CuO and Ag NPs exposure. These results clearly suggest the 
induction of oxidative stress in the erythrocytes, which along with the generation of 
ROS, has been proposed to be one of the primary mechanisms of nanoparticle-
induced toxicity (Nel et al., 2006; Ahamed et al., 2011). This was further confirmed 
by estimating the in vitro generation of ROS by the test samples (Figures 13-15). It 
has been recorded by us that Ag NPs were able to generate hydroxyl radicals to a 
significant extent, while CuO NPs were showing comparatively more generation of 
hydroxyl radicals along with the production of hydrogen peroxide. Superoxide radical 
generation in our system was relatively small. Interestingly, all the three ROS namely, 
superoxide radicals, hydroxyl radicals and hydrogen peroxide, were found to be 
generated to a greater extent by both the ionic forms i.e. CuCb and AgNOs. 
Thus, we can conclude that both the nanoparticles i.e. CuO and Ag NPs are 
significantly phytotoxic, genotoxic as well as cytotoxic; however, CuO NPs were 
found to be more toxic as compared to Ag NPs. Moreover, the ionic forms of these 
nanoparticles were foimd to exhibit a greater degree of toxicity than their respective 
nano forms. Furthermore, the depletion in the activities of SOD and CAT, combined 
with the increased levels of ROS clearly suggest that oxidative stress might be the 
primary mechanism of toxicity induced by these nanoparticles. 
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Nanotechnology deals with the manipulations and applications of engineered 
particles, having atleast one dimension in nano range. It has brought a new 
technological revolution that concerns almost every aspect of human life, making its 
presence felt in areas such as electronics, coatings, optical devices and medicine (Lux 
Report, 2008). In recent years, nanotechnology has been applied in electronic storage 
systems (Kang et al., 1996), biotechnology (Pankhurst et al., 2003), magnetic 
separation and preconcentration of target analytes, targeted drug delivery (Dobson. 
2006; Rudge et al., 2001) and vehicles for gene and drug delivery (Kang et al., 1996; 
Dobson, 2006; Rudge et al., 2001; Appenzeller, 1991). Due to their very small size, 
nanoparticles exhibit extremely high surface area to volume ratio as well as high 
surface reactivity, and therefore, possess unique physicochemical properties different 
from their bulk counterparts. These properties are responsible for the technical 
advantages of nanotechnology and also lead to unique biological effects (Nel et al.. 
2006). 
The study presented here, was carried out to test and compare the potential toxic 
effects of CuO and Ag nanoparticles with that of their respective ionic forms, using a 
battery of toxicity assays including phytotoxicity, genotoxicity and cytotoxicit> tests. 
Moreover, the in vitro generation of ROS by the test NPs was estimated and their 
effects on enzymatic and non-enzymatic antioxidants of human erythrocytes were 
observed. The phytotoxicity assessment of the test NPs as well as their respective 
ionic forms was done by means of seed germination inhibition test, using locally 
available varieties of com, cucumber and moong seeds. Interaction of NPs with calf-
thymus DNA was studied by spectrophotometric and spectrofluorimetric analyses. To 
assess the genotoxic potential of the test samples, comet assay was performed using 
human lymphocytes. Cytotoxicity evaluation was done by means of hemolysis assay 
using human erythrocytes, and the test was further proceeded to prepare hemolysates 
and check the antioxidant status of the cells. 
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The significant findings obtained, along with their possible explanations are given 
below: 
1. Seed germjnatjoii inhibition assay: 
• Both the NPs as well as their respective ionic forms were found to inhibit the 
germination of all the three seeds chosen for the study i.e. com, cucumber and 
moong seeds. 
• Cucumber seeds were found to be the most sensitive among the three seeds, 
for all the test samples except CuO NPs, having the lowest IC50 value. 
• For CuO NPs, com seeds exhibited greatest sensitivity whereas, cucumber 
seeds were least sensitive. 
• CuO NPs found to be more phytotoxic than Ag NPs having lower IC50 values 
for all the three seeds. 
• Ionic forms of the sample exhibited greater phytotoxic effects than their 
respective nano forms. 
2. Spectroscopic studies: 
• UV-Vis spectrophotometric analyses of the test NPs have shown a 
hyperchromic effect for the increasing concentrations of CuO NPs; however, 
hypochromism was observed with Ag NPs. 
• Fluorescence emission spectra of EtBr bound calf thymus DNA resulted in the 
quenching of EtBr fluorescence upon addition of increasing concentrations of 
both the NPs. 
3. Comet assay: 
• A dose-dependent DNA damage was observed with CuO and Ag NPs as well 
as their respective ionic forms, confirming their genotoxic behaviour. 
• Treatment with CuCh and AgNOa resulted in higher values of tail length (a 
DNA damage parameter), suggesting a greater genotoxic potential of ionic 
forms of the test NPs. 
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• CuO NPs were found to be more genotoxic resulting in 9.4% greater DNA 
damage measured in terms of tail length, as compared to Ag NPs, at 500 ppm 
concentration. 
4. Hemolysis assay: 
• A concentration-dependent hemolytic activity was observed with both the 
CuO and Ag NPs. 
• CuO NPs showed greater hemolytic activity as compared to Ag NPs. 
• When exposed to 800 ppm concentration, CuO NPs resulted in 83.3% 
hemolysis whereas, Ag NPs exhibited 75.6%. 
5. Antioxidant status of the cells: 
• CuO as well as Ag NPs produced alterations in enzymatic and non-enzymatic 
antioxidant status of the cells. 
• The activity of SOD decreased in the presence of increasing concentrations of 
CuO and Ag NPs. Exposure to 800 pm concentration of both the NPs resulted 
in the activity reduced to 76.9% and 62.4% respectively. 
• Treatment with the same concentration of CuO and Ag NPs decreased the 
CAT activity to 41.0% and 87.7% respectively. 
• Increasing concentrations of CuO and Ag NPs resulted in only a little 
reduction in GSH level, which is 16.5% and 6.3% respectively at 800 ppm. 
• A dose-dependent increment in MDA level was observed in presence of both 
the NPs. The level increased to 71.4% and 50.0% upon exposure to 800 ppm 
concentration of CuO and Ag NPs. 
6. In vitro ROS generation: 
• Increasing concentrations of CuO and Ag NPs as well as their respective ionic 
forms have been shown to generate ROS viz. superoxide radicals, hydroxyl 
radicals and hydrogen peroxide. 
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• CuO NPs were able to generate all the three species; however, Ag NPs 
generated a remarkable amount of hydroxyl radicals and little amount of 
superoxide radicals. 
• Both the ionic forms were found to produce all the three types of ROS and that 
too of the greater amounts as compared to their respective nano forms. 
Finally, we can confirm that both CuO and Ag NPs possess significant phytotoxic, 
genotoxic and cytotoxic potentials. They are able to generate superoxide radicals, 
hydroxyl radicals as well as hydrogen peroxide, and thereby, induce oxidative stress. 
Thus, both the NPs produced alterations in the activities of antioxidant enzymes and 
the levels of non-enzymatic antioxidants. Furthermore, the studies performed here 
suggest greater toxicity of CuO NPs as compared to Ag NPs and shows the nano 
forms to be less phytotoxic and genotoxic compared to their respective ionic forms. 
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